注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Esperion Therapeutics Inc是一家製藥公司。該公司專註於開發和商業化口服、每日一次的非他汀類藥物,用於治療與低密度脂蛋白膽固醇(LDL-C)升高作鬥爭的患者。該公司的苯乙雙胍和苯乙雙胍、依折麥布復合片是口服的、每日一次的非他汀類降LDL-C藥物,適用於動脈硬化性心血管疾病(ASCVD)或雜合子家族性高膽固醇血癥(HeFH)患者。該公司的產品包括NEXLETOL、NEXLIZET、NILEMDO和NUSTENDI。其NEXLETOL是一種ATP檸檬酸酯酶(ACL)抑製劑,通過減少膽固醇的生物合成和上調LDL受體來降低LDL-C。它的NEXLIZET和NUSTENDI含有硫辛酸和依折麥布,通過抑製膽固醇在肝臟的合成和在腸道的吸收,以互補的作用機製降低升高的LDL-C。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Daniel S. Janney | 56 | 2012 | Independent Director |
Nicole Vitullo | 65 | 2008 | Lead Independent Director |
Antonio M. Gotto | 87 | 2014 | Independent Director |
Sheldon L. Koenig | 56 | 2020 | President, CEO & Director |
Seth H. Z. Fischer | 66 | 2021 | Independent Director |
Alan Fuhrman | 65 | 2020 | Independent Non-Employee Director |
J. Martin Carroll | 74 | 2022 | Independent Chairperson |
Stephen Charles Rocamboli | 51 | 2022 | Independent Director |
Karin Bornfeldt | - | 2022 | Member of Scientific Advisory Board |
Tracy M. Woody | 53 | 2019 | Independent Director |
Jay P. Shepard | 65 | 2018 | Independent Director |
Erin A. Bohula | - | 2022 | Member of Scientific Advisory Board |
Gerald I. Shulman | - | 2022 | Member of Scientific Advisory Board |
R. Preston Mason | - | 2022 | Member of Scientific Advisory Board |
Dennis Bruemmer | - | 2022 | Member of Scientific Advisory Board |
Marilyn Glassberg | - | 2022 | Member of Scientific Advisory Board |
Peter Libby | 76 | 2022 | Member of Scientific Advisory Board |
Pradeep Natarajan | - | 2022 | Member of Scientific Advisory Board |
David E. Cohen | - | 2022 | Member of Scientific Advisory Board |
Jeffrey Bender | - | 2022 | Member of Scientific Advisory Board |
Gabrielle Fredman | - | 2022 | Member of Scientific Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核